Pharsight

Drugs that contain Minocycline Hydrochloride

1. Amzeeq patents expiration

Can you believe AMZEEQ received compensation for the extended wait time during the regulatory approval process?
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10821187 JOURNEY Compositions, gels and foams with rheology modulators and uses thereof
Oct, 2030

(6 years from now)

US8945516 JOURNEY Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
Oct, 2030

(6 years from now)

US10213512 JOURNEY Topical tetracycline compositions
Oct, 2030

(6 years from now)

US10137200 JOURNEY Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
Oct, 2030

(6 years from now)

US8865139 JOURNEY Topical tetracycline compositions
Oct, 2030

(6 years from now)

US9675700 JOURNEY Topical tetracycline compositions
Oct, 2030

(6 years from now)

US8992896 JOURNEY Topical tetracycline compositions
Oct, 2030

(6 years from now)

US10086080 JOURNEY Topical tetracycline compositions
Oct, 2030

(6 years from now)

US10517882 JOURNEY Method for healing of an infected acne lesion without scarring
Oct, 2030

(6 years from now)

US10265404 JOURNEY Compositions, gels and foams with rheology modulators and uses thereof
Oct, 2030

(6 years from now)

US10398641 JOURNEY Compositions and methods for treating rosacea and acne
Sep, 2037

(13 years from now)

US10849847 JOURNEY Compositions and methods for treating rosacea and acne
Sep, 2037

(13 years from now)

Market Authorisation Date: 18 October, 2019

Treatment: Treatment of non-nodular acne vulgaris

Dosage: AEROSOL, FOAM;TOPICAL

How can I launch a generic of AMZEEQ before it's drug patent expiration?
More Information on Dosage

AMZEEQ family patents

Family Patents

2. Arestin patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6682348 ORAPHARMA Dispensing apparatus and cartridge
Mar, 2022

(2 years ago)

US7699609 ORAPHARMA Dispensing apparatus and cartridge with deformable tip
Mar, 2022

(2 years ago)

Market Authorisation Date: 16 February, 2001

Treatment: NA

Dosage: POWDER, EXTENDED RELEASE;DENTAL

More Information on Dosage

ARESTIN family patents

Family Patents

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

3. Minocin patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9084802 REMPEX Tetracycline compositions
May, 2031

(6 years from now)

US9278105 REMPEX Tetracycline compositions
May, 2031

(6 years from now)

US11944634 REMPEX Tetracycline compositions
Oct, 2032

(8 years from now)

Treatment: Method of treating bacterial infections

Dosage: INJECTABLE;INJECTION

How can I launch a generic of MINOCIN before it's drug patent expiration?
More Information on Dosage

MINOCIN family patents

Family Patents

4. Minolira patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11103517 EPI HLTH Pharmaceutical compositions for minocycline
Apr, 2036

(11 years from now)

Market Authorisation Date: 08 May, 2017

Treatment: NA

Dosage: TABLET, EXTENDED RELEASE;ORAL

More Information on Dosage

MINOLIRA family patents

Family Patents

5. Solodyn patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5908838 BAUSCH Method for the treatment of acne
Feb, 2018

(6 years ago)

US7790705 BAUSCH Minocycline oral dosage forms for the treatment of acne
Jun, 2025

(1 year, 25 days from now)

US8252776 BAUSCH Minocycline oral dosage forms for the treatment of acne
Jun, 2025

(1 year, 25 days from now)

US8268804 BAUSCH Minocycline oral dosage forms for the treatment of acne
Jun, 2025

(1 year, 25 days from now)

US8722650 BAUSCH Extended-release minocycline dosage forms
Jun, 2025

(1 year, 25 days from now)

US7919483 BAUSCH Method for the treatment of acne
Mar, 2027

(2 years from now)

US7544373 BAUSCH Minocycline oral dosage forms for the treatment of acne
Apr, 2027

(2 years from now)

US7541347 BAUSCH Minocycline oral dosage forms for the treatment of acne
Apr, 2027

(2 years from now)

US9192615 BAUSCH Method for the treatment of acne and certain dosage forms thereof
Nov, 2031

(7 years from now)

Market Authorisation Date: 08 May, 2006

Treatment: Treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris; Treatment of acne

Dosage: TABLET, EXTENDED RELEASE;ORAL

How can I launch a generic of SOLODYN before it's drug patent expiration?
More Information on Dosage

SOLODYN family patents

Family Patents

6. Ximino patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5908838 JOURNEY Method for the treatment of acne
Feb, 2018

(6 years ago)

US8268804 JOURNEY Minocycline oral dosage forms for the treatment of acne
Jun, 2025

(1 year, 25 days from now)

US7790705 JOURNEY Minocycline oral dosage forms for the treatment of acne
Jun, 2025

(1 year, 25 days from now)

US8252776 JOURNEY Minocycline oral dosage forms for the treatment of acne
Jun, 2025

(1 year, 25 days from now)

US7919483 JOURNEY Method for the treatment of acne
Mar, 2027

(2 years from now)

US7544373 JOURNEY Minocycline oral dosage forms for the treatment of acne
Apr, 2027

(2 years from now)

US7541347 JOURNEY Minocycline oral dosage forms for the treatment of acne
Apr, 2027

(2 years from now)

Market Authorisation Date: 11 July, 2012

Treatment: Treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris; Treatment of acne

Dosage: CAPSULE, EXTENDED RELEASE;ORAL

More Information on Dosage

XIMINO family patents

Family Patents

7. Zilxi patents expiration

Can you believe ZILXI received compensation for the extended wait time during the regulatory approval process?
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10213512 JOURNEY Topical tetracycline compositions
Oct, 2030

(6 years from now)

US8992896 JOURNEY Topical tetracycline compositions
Oct, 2030

(6 years from now)

US9675700 JOURNEY Topical tetracycline compositions
Oct, 2030

(6 years from now)

US8865139 JOURNEY Topical tetracycline compositions
Oct, 2030

(6 years from now)

US10322186 JOURNEY Topical tetracycline compositions
Oct, 2030

(6 years from now)

US10946101 JOURNEY Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
Oct, 2030

(6 years from now)

US8945516 JOURNEY Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
Oct, 2030

(6 years from now)

US10265404 JOURNEY Compositions, gels and foams with rheology modulators and uses thereof
Oct, 2030

(6 years from now)

Market Authorisation Date: 28 May, 2020

Treatment: Treatment of inflammatory lesions of rosacea.

Dosage: AEROSOL, FOAM;TOPICAL

How can I launch a generic of ZILXI before it's drug patent expiration?
More Information on Dosage

ZILXI family patents

Family Patents